Literature DB >> 12731677

Serum immunoglobulin levels at onset: association with the prognosis of childhood idiopathic thrombocytopenic purpura.

Masaru Kubota1, Ikuya Usami, Ken-ichiro Kobayashi, Tsutomu Tsutsui, Kousaku Matsubara.   

Abstract

Between 1981 and 2000, 87 patients with new diagnoses of idiopathic thrombocytopenic purpura (ITP) were admitted to the pediatric department of Kobe City General Hospital or Nishi-Kobe Medical Center. The patients' clinical records were analyzed for the relationships of disease outcome to serum immunoglobulin levels and other factors, including sex, onset age, and initial platelet counts. The disease of 22 patients became chronic, and of the 65 patients with an acute form of the disease, 27 exhibited levels of immunoglobulin G (IgG), IgA, or IgM above the 97.5% confidence limits of the age-matched control subjects. However, only 2 patients with the chronic form of the disease showed elevated serum immunoglobulin levels. The presence of antecedent specific viral infections was also associated with the acute disease form. In predicting the prognosis of childhood ITP, high serum immunoglobulin levels at initial presentation can be considered a good prognostic marker for the acute form of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731677     DOI: 10.1007/bf02983791

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

Review 1.  Management of childhood idiopathic thrombocytopenic purpura.

Authors:  J S Lilleyman
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

2.  Idiopathic thrombocytopenic purpura in children.

Authors:  S M Simons; C A Main; H M Yaish; J Rutzky
Journal:  J Pediatr       Date:  1975-07       Impact factor: 4.406

3.  Childhood idiopathic thrombocytopenic purpura: report of 60 cases from Kuwait.

Authors:  M Zaki; A A Hassanein; A F Khalil
Journal:  J Trop Pediatr       Date:  1990-02       Impact factor: 1.165

Review 4.  Virus-associated idiopathic thrombocytopenic purpura.

Authors:  M L Rand; J F Wright
Journal:  Transfus Sci       Date:  1998-09

5.  A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.

Authors:  K Fujisawa; H Iyori; H Ohkawa; S Konishi; F Bessho; A Shirahata; S Miyazaki; J Akatsuka
Journal:  Int J Hematol       Date:  2000-10       Impact factor: 2.490

Review 6.  Idiopathic thrombocytopenic purpura in children.

Authors:  J M Lusher; R Iyer
Journal:  Semin Thromb Hemost       Date:  1977-01       Impact factor: 4.180

7.  Idiopathic thrombocytopenic purpura: predictors of chronic disease.

Authors:  L G Robb; K Tiedeman
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

8.  Immunoglobulins in idiopathic thrombocytopenic purpura in childhood.

Authors:  A S Khalifa; J M Lusher; J Cejka; W W Zuelzer
Journal:  Acta Haematol       Date:  1976       Impact factor: 2.195

9.  Idiopathic thrombocytopenia, initial illness and long term follow up.

Authors:  R W Walker; W Walker
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

10.  Thrombocytopenia in childhood: an evaluation of 433 patients.

Authors:  J Cohn
Journal:  Scand J Haematol       Date:  1976-03
View more
  2 in total

Review 1.  Clinical practice: immune thrombocytopenia in paediatrics.

Authors:  Veerle Labarque; Chris Van Geet
Journal:  Eur J Pediatr       Date:  2014-01-05       Impact factor: 3.183

2.  Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study.

Authors:  Masaru Kubota; Souichi Adachi; Ikuya Usami; Masayuki Okada; Toshiyuki Kitoh; Mitsutaka Shiota; Yoshihiro Taniguchi; Akihiko Tanizawa; Mitsuhiko Nanbu; Keigo Hamahata; Hisanori Fujino; Kousaku Matsubara; Yoshihiro Wakazono; Tatsutoshi Nakahata
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.